Cambium Bio Limited has released a press release.
Quarterly Activities/Appendix 4C Cash Flow Report
Earlier from Cambium Bio
- Cambium Bio Secures A$2.4 Million Strategic Investment
- Cambium Bio Signs Strategic MoU with Benta SAS
- Cambium Bio Signs US$2.0M plus Licensing Deal
- FY25 Appendix 4E and Annual Report
